InspireMD hopes to secure $13.8 million through a public offering of warrants and company stock. The Boston-based firm will use the money to introduce its CGuard MicroNet carotid stent and other products.
Sen. Max Baucus, D-Mont., who was the chief author of the Affordable Care Act, likely won't support overturning the 2.3% medical device tax while he's still in office, AdvaMed's J.C. Scott said. But the news about the senator stepping down next year could change the game on the repeal effort, which Scott said still involves making it a part of a broader package such as a corporate tax reform.
The FDA has given Olympus Medical 510(k) clearance to market its Articulating HD 3D system, which is used to aid surgeons in performing laparoscopic procedures more efficiently and accurately. The device adds another 3D video-imaging option to the firm's Evis Exera III technology.
Varian Medical Systems posted $768 million in revenue and $113 million in net profit during its fiscal second quarter, up from $720 million and $108 million, respectively, over the same period a year ago. Contributing to this growth are increased revenue for the company's X-Ray products unit and oncology systems division.
ResMed is announcing the U.S. launch of its VPAP COPD system, which recently obtained clearance from the FDA. The bilevel positive air pressure device is designed to provide assisted breathing to patients with chronic obstructive pulmonary disease and other respiratory disorders while they are asleep.